Daktronics 8-K 2007
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 15, 2007
(Exact name of registrant as specified in its charter)
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFT 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 5 - Corporate Governance and Management
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensating Arrangements of Certain Officers
(a) On November 15, 2007, the Compensation Committee of the Board of Directors of Daktronics, Inc. (the Company) recommended and the Board of Directors approved a change in the compensation plans for James B. Morgan, the Chief Executive Officer of the Company, William R. Retterath, the Chief Financial Officer of the Company, and Bradley T. Wiemann and Reece A. Kurtenbach, both Vice Presidents of the Company. Each individual earns a fixed salary (described below).
The Compensation Committee of the Board of Directors also recommended and the Board of Directors approved a continuation and modification of the formula-based performance bonus plan for certain executive officers consisting of thirty per cent (30%) of the maximum bonus if after-tax earnings exceed 13% of shareholders equity at the beginning of the 2008 fiscal year, and increasing linearly with performance to a maximum bonus amount if after-tax earnings exceed 20% of beginning shareholders equity. The maximum bonus amount for Mr. Morgan is seven months of salary. Mr. Retterath's maximum bonus is five months of salary, Mr. R. Kurtenbachs and Mr. Wiemanns maximum bonuses are four and one-half months of salary, and Dr. Aelred J. Kurtenbachs maximum bonus is three months of salary.
Also, effective November 15, 2007, the Board of Directors authorized grants of stock options to purchase shares of the Companys common stock under the Companys 2007 Stock Option Plan (the Plan) to various executive officers in the amounts indicated below. Each of these new stock options vests over five years, has a ten-year term, is subject to the terms and conditions of the Plan, and has an exercise price equal to the fair market value as of the grant date, which was $20.07. Copies of the Plan and the form of agreement under which these options were granted are on file with the Securities and Exchange Commission as exhibits to the Companys reports.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: November 15, 2007